Frazier Life Sciences — 2015 Investments
10 investments dated 2015 · listed companies and verified rows first · show all
AnaptysBio manages the financial collaborations from Jemperli (with GSK) and imsidolimab (with Vanda), operating a virtual model focused on protecting and returning royalty and milestone value to stockholders.
BiotechSan Diego, US
Robert Hoffman(Executive Officer)Carol Gallagher(Director)Marco Londei(Executive Officer)John Schmid(Director)Nicholas Lydon(Director)Hamza Suria(Executive Officer, Director)
Board seatJames N. Topper· per SEC Form D
BiotechCanton, US
Gino Santini(Director)Eran Nadav(Director)John Freund(Director)Garen Bohlin(Director)David Hirsch(Director)Michael Heffernan(Executive Officer, Director)
Board seatPatrick Heron· per SEC Form D
BiotechNewton, US
Axel Bolte(Director)James Topper(Director)Alexey Margolin(Executive Officer, Director)Gino Santini(Director)Louis Brenner(Executive Officer)Stephen Kraus(Director)
Board seatJames N. Topper· per SEC Form D · $53M raise · filed Dec 2015
BiotechCleveland, US
Kevin Lalande(Director)Howard Dittrich(Executive Officer)Robert Baltera, Jr.(Executive Officer, Director)Jerel Davis(Director)James Topper(Director)
Board seatJames N. Topper· per SEC Form D · $31.9M raise · filed Feb 2015
Pharmaceutical company developing medicines and vaccines for patient health and treatment.
BiotechHealthtechSan Diego, US
Jeffrey Stein(Executive Officer, Director)Steve Elms(Director)Dan Burgess(Director)Ted Schroeder(Director)Kevin Forrest(Executive Officer)Dirk Thye(Executive Officer)
Board seatPatrick Heron· per SEC Form D
HealthtechLong Beach, US
Keith Arnold(Executive Officer)Richard Whitney(Director)DAVID KOSLOFF(Director)Rob Mahan(Executive Officer)Jim Adams(Executive Officer)Vera Appleyard(Executive Officer)
Board seatNader Naini· per SEC Form D · $14.4M raise · filed Nov 2015
BiotechKing Of Prussia, US
James Topper(Director)Colin Goddard(Director)Markus Goebel(Director)Brian MacDonald(Executive Officer, Director)Remy Sukhija(Executive Officer)Jeffrey Bird(Director)
Board seatJames N. Topper· per SEC Form D · $17.1M raise · filed Apr 2016
Menlo Park, US
Yigong Ge(Director)Chen Yu(Director)Brent Ahrens(Director)David Socks(Executive Officer, Director, Promoter)
Board seatPatrick Heron· per SEC Form D · $21.3M raise · filed Jun 2015
BiotechGreenwood Village, US
Frank Segrave(President)Michael Beckloff(Chief Development Officer)Robert Mauro(Chief Operating Officer)Bhaskar Chaundhuri(Director)Nathan Every(Director)Barry Barnard(Chief Financial Officer)
Board seatPatrick HeronNathan Every· per SEC Form D · $4.6M raise · filed Oct 2015
BiotechSan Diego, US
Valerie Harding, Ph.D.(Senior Vice President, Chemistry, Manufacturing and Controls)Bernard Parker(Chief Commercial Officer)Zachary Hornby(Chief Operating Officer)Igor P. Bilinsky, Ph.D.(Executive Officer)Matt Onaitis, J.D.(Secretary and General Counsel)Robert Wild, Ph.D.(Chief Scientific Officer and SVP, Research)
PartnerPatrick Heron· led
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.